

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.02646334 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.71429826 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.65410319 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65410319 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 4.24165342 |
| 6 | detection of external biotic stimulus (GO:0098581) | 4.12516648 |
| 7 | valine metabolic process (GO:0006573) | 4.08211796 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.03220619 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.03220619 |
| 10 | urea metabolic process (GO:0019627) | 4.00487551 |
| 11 | urea cycle (GO:0000050) | 4.00487551 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 3.95739841 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93130608 |
| 14 | cellular extravasation (GO:0045123) | 3.92731697 |
| 15 | detection of other organism (GO:0098543) | 3.88703282 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.88398681 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.86688435 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.86688435 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.86688435 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 3.80563906 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.80036351 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.80036351 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.77793568 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.76590365 |
| 25 | lysine catabolic process (GO:0006554) | 3.74216918 |
| 26 | lysine metabolic process (GO:0006553) | 3.74216918 |
| 27 | kynurenine metabolic process (GO:0070189) | 3.73102923 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.70800397 |
| 29 | response to peptidoglycan (GO:0032494) | 3.70296395 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.69884225 |
| 31 | glucocorticoid biosynthetic process (GO:0006704) | 3.68925829 |
| 32 | microglial cell activation (GO:0001774) | 3.67433024 |
| 33 | phospholipid homeostasis (GO:0055091) | 3.63777677 |
| 34 | protein carboxylation (GO:0018214) | 3.55144293 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.55144293 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 3.54903312 |
| 37 | detection of bacterium (GO:0016045) | 3.54674715 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53312261 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.53019513 |
| 40 | response to host immune response (GO:0052572) | 3.51411374 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51411374 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.49940825 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49094936 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49094936 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40834119 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40536558 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.40278778 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37461470 |
| 49 | response to host (GO:0075136) | 3.37461470 |
| 50 | response to host defenses (GO:0052200) | 3.37461470 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.37320901 |
| 52 | alpha-linolenic acid metabolic process (GO:0036109) | 3.36009086 |
| 53 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35395531 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34705899 |
| 55 | bile acid biosynthetic process (GO:0006699) | 3.31489683 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.30597480 |
| 57 | macrophage activation (GO:0042116) | 3.25845172 |
| 58 | regulation of protein activation cascade (GO:2000257) | 3.25005590 |
| 59 | cysteine metabolic process (GO:0006534) | 3.24987162 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.22794280 |
| 61 | germinal center formation (GO:0002467) | 3.22443272 |
| 62 | glucocorticoid metabolic process (GO:0008211) | 3.21306104 |
| 63 | negative thymic T cell selection (GO:0045060) | 3.20101996 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 3.18207557 |
| 65 | response to interleukin-15 (GO:0070672) | 3.16656061 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16083385 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 3.15502515 |
| 68 | fatty acid transmembrane transport (GO:1902001) | 3.15273365 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.15139903 |
| 70 | positive thymic T cell selection (GO:0045059) | 3.14960927 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12577513 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.11292479 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.11292479 |
| 74 | response to type I interferon (GO:0034340) | 3.10111161 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09950709 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09745346 |
| 77 | regulation of complement activation (GO:0030449) | 3.08362221 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.07552436 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 3.07544676 |
| 80 | negative T cell selection (GO:0043383) | 3.06775004 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 3.06551920 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 3.03882404 |
| 83 | regulation of B cell differentiation (GO:0045577) | 3.03208284 |
| 84 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02672901 |
| 85 | phospholipid efflux (GO:0033700) | 3.01767329 |
| 86 | oxaloacetate metabolic process (GO:0006107) | 3.00896573 |
| 87 | glyoxylate metabolic process (GO:0046487) | 3.00223653 |
| 88 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.96527562 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95400562 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95400562 |
| 91 | positive regulation of interferon-alpha production (GO:0032727) | 2.94969673 |
| 92 | regulation of sequestering of triglyceride (GO:0010889) | 2.94099607 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92817713 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92729239 |
| 95 | bile acid metabolic process (GO:0008206) | 2.91384655 |
| 96 | T cell migration (GO:0072678) | 2.91156055 |
| 97 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90355187 |
| 98 | leukocyte aggregation (GO:0070486) | 2.89937636 |
| 99 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89281764 |
| 100 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89164417 |
| 101 | high-density lipoprotein particle remodeling (GO:0034375) | 2.87865532 |
| 102 | response to muramyl dipeptide (GO:0032495) | 2.86939536 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 2.86401335 |
| 104 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85686121 |
| 105 | carnitine shuttle (GO:0006853) | 2.83977371 |
| 106 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83820162 |
| 107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83726112 |
| 108 | cellular response to epinephrine stimulus (GO:0071872) | 2.83481916 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 2.82413428 |
| 110 | neutrophil activation (GO:0042119) | 2.82082957 |
| 111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80545152 |
| 112 | regulation of interferon-alpha production (GO:0032647) | 2.79785606 |
| 113 | triglyceride homeostasis (GO:0070328) | 2.77585586 |
| 114 | acylglycerol homeostasis (GO:0055090) | 2.77585586 |
| 115 | regulation of macrophage cytokine production (GO:0010935) | 2.77424963 |
| 116 | T-helper 1 type immune response (GO:0042088) | 2.75154035 |
| 117 | fatty acid oxidation (GO:0019395) | 2.74713517 |
| 118 | regulation of cholesterol storage (GO:0010885) | 2.74556066 |
| 119 | B cell mediated immunity (GO:0019724) | 2.72418350 |
| 120 | cellular response to interleukin-15 (GO:0071350) | 2.72289650 |
| 121 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71862382 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.71828172 |
| 123 | cellular glucuronidation (GO:0052695) | 2.71775492 |
| 124 | positive regulation of mast cell activation (GO:0033005) | 2.71646277 |
| 125 | aromatic amino acid family metabolic process (GO:0009072) | 2.71063961 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 2.70992606 |
| 127 | serine family amino acid catabolic process (GO:0009071) | 2.70572743 |
| 128 | positive T cell selection (GO:0043368) | 2.70172974 |
| 129 | lipid oxidation (GO:0034440) | 2.70145090 |
| 130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69471655 |
| 131 | indolalkylamine metabolic process (GO:0006586) | 2.68901876 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.67180828 |
| 133 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66953803 |
| 134 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66953803 |
| 135 | modulation by symbiont of host immune response (GO:0052553) | 2.66953803 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66953803 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.66953803 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66953803 |
| 139 | regulation of mast cell degranulation (GO:0043304) | 2.66876581 |
| 140 | complement activation, classical pathway (GO:0006958) | 2.66643643 |
| 141 | drug catabolic process (GO:0042737) | 2.66060034 |
| 142 | reverse cholesterol transport (GO:0043691) | 2.65318857 |
| 143 | negative regulation of cholesterol transport (GO:0032375) | 2.64985109 |
| 144 | negative regulation of sterol transport (GO:0032372) | 2.64985109 |
| 145 | granulocyte activation (GO:0036230) | 2.64852479 |
| 146 | defense response to protozoan (GO:0042832) | 2.64304476 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.63275282 |
| 148 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62423618 |
| 149 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.62346729 |
| 150 | negative regulation of lipid storage (GO:0010888) | 2.62139069 |
| 151 | T cell selection (GO:0045058) | 2.61898954 |
| 152 | tricarboxylic acid metabolic process (GO:0072350) | 2.60024154 |
| 153 | positive regulation of fatty acid oxidation (GO:0046321) | 2.60004699 |
| 154 | acetyl-CoA metabolic process (GO:0006084) | 2.59895858 |
| 155 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59477962 |
| 156 | low-density lipoprotein particle clearance (GO:0034383) | 2.59029782 |
| 157 | complement activation (GO:0006956) | 2.58697765 |
| 158 | cellular ketone body metabolic process (GO:0046950) | 2.58587852 |
| 159 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58444273 |
| 160 | alpha-amino acid catabolic process (GO:1901606) | 2.58099879 |
| 161 | acute-phase response (GO:0006953) | 2.57608529 |
| 162 | neutrophil mediated immunity (GO:0002446) | 2.57604117 |
| 163 | negative regulation of type 2 immune response (GO:0002829) | 2.57443303 |
| 164 | positive regulation of B cell differentiation (GO:0045579) | 2.57416112 |
| 165 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.55703536 |
| 166 | fatty acid catabolic process (GO:0009062) | 2.55239410 |
| 167 | bile acid and bile salt transport (GO:0015721) | 2.55219663 |
| 168 | negative regulation of fibrinolysis (GO:0051918) | 2.54939232 |
| 169 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53924445 |
| 170 | regulation of platelet aggregation (GO:0090330) | 2.53815885 |
| 171 | protein-lipid complex remodeling (GO:0034368) | 2.53446305 |
| 172 | macromolecular complex remodeling (GO:0034367) | 2.53446305 |
| 173 | plasma lipoprotein particle remodeling (GO:0034369) | 2.53446305 |
| 174 | cellular modified amino acid catabolic process (GO:0042219) | 2.53184254 |
| 175 | thymic T cell selection (GO:0045061) | 2.52394866 |
| 176 | ethanol oxidation (GO:0006069) | 2.52138412 |
| 177 | response to protozoan (GO:0001562) | 2.52084259 |
| 178 | respiratory burst (GO:0045730) | 2.52023912 |
| 179 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51660006 |
| 180 | plasma lipoprotein particle assembly (GO:0034377) | 2.51641071 |
| 181 | tyrosine metabolic process (GO:0006570) | 2.51514791 |
| 182 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51382460 |
| 183 | negative regulation of interleukin-17 production (GO:0032700) | 2.50962430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.67946366 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42516795 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.09528201 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.88688369 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.78017247 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47101891 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10869756 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.07267075 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.01008946 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00008922 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.76917007 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64570691 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49371454 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39142431 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35389253 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32070980 |
| 17 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29596687 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26292385 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10501766 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07951629 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96756214 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92832784 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84031173 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82206989 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79986377 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76830773 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75622686 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74666472 |
| 29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73269167 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70608786 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69856082 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66175919 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.64502196 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63158281 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61504733 |
| 36 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58624425 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58077938 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57138599 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56824705 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48895230 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40323857 |
| 42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40151576 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36986945 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34014630 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33005907 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26564508 |
| 47 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.25144183 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24906782 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24531453 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24091780 |
| 51 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23007734 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21346939 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.21261932 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21058249 |
| 55 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17948354 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17804572 |
| 57 | * MYB_26560356_Chip-Seq_TH1_Human | 1.17669815 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15482794 |
| 59 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.12491796 |
| 60 | MAF_26560356_Chip-Seq_TH1_Human | 1.11577648 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07079843 |
| 62 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06530010 |
| 63 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06530010 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06006541 |
| 65 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05004356 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03053035 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02798817 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02216637 |
| 69 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.02181028 |
| 70 | * MAF_26560356_Chip-Seq_TH2_Human | 1.01422130 |
| 71 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00976873 |
| 72 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99563607 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99377449 |
| 74 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99327534 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99237409 |
| 76 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99120486 |
| 77 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98379999 |
| 78 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97991647 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97083799 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96643202 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95075713 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94981348 |
| 83 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94072717 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93452130 |
| 85 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.93272615 |
| 86 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92713982 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92547968 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92525253 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91397346 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91248693 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90665971 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90473946 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90252987 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88580650 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.88235383 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87852239 |
| 97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87191089 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84280094 |
| 99 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83974612 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83382901 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83213769 |
| 102 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.83156788 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82395383 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81791476 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81703049 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81414681 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81190893 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81001164 |
| 109 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.80512201 |
| 110 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80437593 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80146814 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.79253945 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78560755 |
| 114 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77713116 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77503865 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76716127 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76334442 |
| 118 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76144195 |
| 119 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75243727 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75018114 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74439548 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73813424 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73589216 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.73197509 |
| 125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73091285 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72572293 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71182695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.62200336 |
| 2 | MP0005360_urolithiasis | 4.37591866 |
| 3 | MP0005365_abnormal_bile_salt | 3.84329152 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.62277639 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 2.87899602 |
| 6 | MP0008004_abnormal_stomach_pH | 2.70568393 |
| 7 | MP0003252_abnormal_bile_duct | 2.50929768 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.49017535 |
| 9 | MP0004510_myositis | 2.45643179 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.35780220 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.33098514 |
| 12 | MP0003303_peritoneal_inflammation | 2.32923392 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.31966881 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.31178200 |
| 15 | MP0009840_abnormal_foam_cell | 2.17585492 |
| 16 | MP0003436_decreased_susceptibility_to | 2.12128302 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.03971122 |
| 18 | MP0001790_abnormal_immune_system | 1.92169336 |
| 19 | MP0005387_immune_system_phenotype | 1.92169336 |
| 20 | MP0000609_abnormal_liver_physiology | 1.82037600 |
| 21 | MP0003195_calcinosis | 1.80630379 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.78262785 |
| 23 | MP0005332_abnormal_amino_acid | 1.77620871 |
| 24 | MP0003828_pulmonary_edema | 1.77303912 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 1.76840971 |
| 26 | MP0003646_muscle_fatigue | 1.73751635 |
| 27 | MP0001800_abnormal_humoral_immune | 1.73133496 |
| 28 | MP0008260_abnormal_autophagy | 1.71340807 |
| 29 | MP0004130_abnormal_muscle_cell | 1.69282415 |
| 30 | MP0000685_abnormal_immune_system | 1.66111490 |
| 31 | MP0002254_reproductive_system_inflammat | 1.59954711 |
| 32 | MP0002419_abnormal_innate_immunity | 1.58740321 |
| 33 | MP0004883_abnormal_blood_vessel | 1.56115707 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.55341801 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.49550872 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.49201229 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.48182710 |
| 38 | MP0003690_abnormal_glial_cell | 1.47880925 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.47776160 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.47092282 |
| 41 | MP0001853_heart_inflammation | 1.45231482 |
| 42 | MP0009764_decreased_sensitivity_to | 1.42953286 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.41882637 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.41455358 |
| 45 | MP0005670_abnormal_white_adipose | 1.41229242 |
| 46 | MP0005083_abnormal_biliary_tract | 1.41003134 |
| 47 | MP0002722_abnormal_immune_system | 1.39735099 |
| 48 | MP0003724_increased_susceptibility_to | 1.38461032 |
| 49 | MP0009785_altered_susceptibility_to | 1.37965209 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.37755820 |
| 51 | MP0001851_eye_inflammation | 1.36879712 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.35691358 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.35043925 |
| 54 | MP0008469_abnormal_protein_level | 1.34500483 |
| 55 | MP0002429_abnormal_blood_cell | 1.34219843 |
| 56 | MP0005025_abnormal_response_to | 1.33427822 |
| 57 | MP0002723_abnormal_immune_serum | 1.33185290 |
| 58 | MP0003866_abnormal_defecation | 1.29556823 |
| 59 | MP0003091_abnormal_cell_migration | 1.28703763 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.27787903 |
| 61 | MP0009278_abnormal_bone_marrow | 1.27499269 |
| 62 | MP0005671_abnormal_response_to | 1.26852361 |
| 63 | MP0000858_altered_metastatic_potential | 1.26535915 |
| 64 | MP0004947_skin_inflammation | 1.25774745 |
| 65 | MP0005164_abnormal_response_to | 1.25619162 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.24768981 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.24543965 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.23263024 |
| 69 | MP0002006_tumorigenesis | 1.22758151 |
| 70 | MP0006082_CNS_inflammation | 1.22312528 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.22156590 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19543827 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.18422369 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.15913281 |
| 75 | MP0001819_abnormal_immune_cell | 1.14596372 |
| 76 | MP0003868_abnormal_feces_composition | 1.14566719 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.14542558 |
| 78 | MP0001873_stomach_inflammation | 1.14261042 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.12145284 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.10864630 |
| 81 | MP0003075_altered_response_to | 1.09705342 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.09248187 |
| 83 | MP0005535_abnormal_body_temperature | 1.05923410 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.05833163 |
| 85 | MP0002136_abnormal_kidney_physiology | 1.05486669 |
| 86 | MP0009763_increased_sensitivity_to | 1.05422827 |
| 87 | MP0002009_preneoplasia | 1.05035060 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.03878117 |
| 89 | MP0001764_abnormal_homeostasis | 1.03833960 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 1.03224126 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 1.01609002 |
| 92 | MP0000249_abnormal_blood_vessel | 1.01097880 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.96889884 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.96037205 |
| 95 | MP0005451_abnormal_body_composition | 0.95417092 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.94931872 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 0.94931872 |
| 98 | MP0004381_abnormal_hair_follicle | 0.93294015 |
| 99 | MP0003448_altered_tumor_morphology | 0.92586882 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.92126602 |
| 101 | MP0000598_abnormal_liver_morphology | 0.91455173 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.90522682 |
| 103 | * MP0005166_decreased_susceptibility_to | 0.89913062 |
| 104 | MP0005334_abnormal_fat_pad | 0.89750379 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.89588001 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.89577151 |
| 107 | MP0000604_amyloidosis | 0.89535508 |
| 108 | MP0000716_abnormal_immune_system | 0.88970605 |
| 109 | MP0005310_abnormal_salivary_gland | 0.88952708 |
| 110 | MP0002405_respiratory_system_inflammati | 0.88706091 |
| 111 | MP0002971_abnormal_brown_adipose | 0.88079528 |
| 112 | MP0003329_amyloid_beta_deposits | 0.87297382 |
| 113 | MP0005647_abnormal_sex_gland | 0.86821197 |
| 114 | MP0002928_abnormal_bile_duct | 0.86126235 |
| 115 | MP0003045_fibrosis | 0.85975576 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.85489833 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.84829612 |
| 118 | MP0001756_abnormal_urination | 0.83553295 |
| 119 | * MP0000343_altered_response_to | 0.82789688 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.82637070 |
| 121 | MP0002398_abnormal_bone_marrow | 0.82509900 |
| 122 | MP0002132_abnormal_respiratory_system | 0.82301512 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.82039979 |
| 124 | * MP0008874_decreased_physiological_sensi | 0.81673123 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.80922253 |
| 126 | MP0004036_abnormal_muscle_relaxation | 0.80236775 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.79801751 |
| 128 | MP0002933_joint_inflammation | 0.79798138 |
| 129 | MP0003186_abnormal_redox_activity | 0.79545400 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.78228762 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.77529313 |
| 132 | MP0000920_abnormal_myelination | 0.77363113 |
| 133 | MP0008057_abnormal_DNA_replication | 0.76220716 |
| 134 | MP0003279_aneurysm | 0.71892626 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.70455983 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.69728956 |
| 137 | MP0005390_skeleton_phenotype | 0.69214998 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.65296851 |
| 139 | MP0009115_abnormal_fat_cell | 0.61730789 |
| 140 | MP0001663_abnormal_digestive_system | 0.60521487 |
| 141 | MP0005165_increased_susceptibility_to | 0.59904446 |
| 142 | MP0003795_abnormal_bone_structure | 0.59100247 |
| 143 | MP0001958_emphysema | 0.57390769 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.57092598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.27441250 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.14587784 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.09809973 |
| 4 | Orchitis (HP:0100796) | 4.05787484 |
| 5 | Complement deficiency (HP:0004431) | 4.05060355 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.97822077 |
| 7 | Optic neuritis (HP:0100653) | 3.97822077 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.89402580 |
| 9 | Xanthomatosis (HP:0000991) | 3.78570578 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.65210606 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.55057877 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.47832587 |
| 13 | Myocardial infarction (HP:0001658) | 3.38251610 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.36524806 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29308256 |
| 16 | Ketosis (HP:0001946) | 3.27841765 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25162138 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.19924401 |
| 19 | Joint hemorrhage (HP:0005261) | 3.19269052 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.16538558 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.16423000 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.13206196 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.11394243 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.09423433 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.09160976 |
| 26 | T lymphocytopenia (HP:0005403) | 3.05825665 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.05398170 |
| 28 | Epidermoid cyst (HP:0200040) | 3.03810973 |
| 29 | Stomatitis (HP:0010280) | 3.03620851 |
| 30 | Ketoacidosis (HP:0001993) | 3.02405791 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.02054857 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.02000048 |
| 33 | Abnormality of complement system (HP:0005339) | 2.98351319 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97826394 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97826394 |
| 36 | Hyperammonemia (HP:0001987) | 2.97720427 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.96212745 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.92701643 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.91159242 |
| 40 | Glomerulonephritis (HP:0000099) | 2.90233914 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.89665287 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.89294963 |
| 43 | Obstructive lung disease (HP:0006536) | 2.88869547 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88869547 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.82986917 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.81123216 |
| 47 | Gout (HP:0001997) | 2.80364408 |
| 48 | Hypolipoproteinemia (HP:0010981) | 2.78559508 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.75553530 |
| 50 | Encephalitis (HP:0002383) | 2.75285462 |
| 51 | Hyperglycinuria (HP:0003108) | 2.74319279 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.69650100 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.66976253 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.66921400 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65128163 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.64921677 |
| 57 | Osteomyelitis (HP:0002754) | 2.64607587 |
| 58 | Chest pain (HP:0100749) | 2.63552268 |
| 59 | Colitis (HP:0002583) | 2.61321883 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.61146891 |
| 61 | Increased IgE level (HP:0003212) | 2.59498447 |
| 62 | Gingival bleeding (HP:0000225) | 2.59194263 |
| 63 | Urticaria (HP:0001025) | 2.58818425 |
| 64 | Hemoptysis (HP:0002105) | 2.57846599 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.57249878 |
| 66 | Mitral stenosis (HP:0001718) | 2.54322952 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.52080078 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.51730840 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.51558307 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.49744507 |
| 71 | Nephritis (HP:0000123) | 2.47699604 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47172351 |
| 73 | Esophageal varix (HP:0002040) | 2.36390225 |
| 74 | Abnormality of T cells (HP:0002843) | 2.36167839 |
| 75 | Fat malabsorption (HP:0002630) | 2.34815496 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.33778078 |
| 77 | Mediastinal lymphadenopathy (HP:0100721) | 2.33366504 |
| 78 | Pulmonary embolism (HP:0002204) | 2.32938991 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.26431048 |
| 80 | Viral hepatitis (HP:0006562) | 2.25305132 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.24958294 |
| 82 | Panhypogammaglobulinemia (HP:0003139) | 2.23733900 |
| 83 | Abnormal platelet volume (HP:0011876) | 2.22853806 |
| 84 | Hematochezia (HP:0002573) | 2.21932257 |
| 85 | Purpura (HP:0000979) | 2.21702713 |
| 86 | Conjugated hyperbilirubinemia (HP:0002908) | 2.21337628 |
| 87 | Periodontitis (HP:0000704) | 2.20500827 |
| 88 | Petechiae (HP:0000967) | 2.20331534 |
| 89 | Recurrent skin infections (HP:0001581) | 2.20137754 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.19189738 |
| 91 | Gingivitis (HP:0000230) | 2.18786343 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.18223475 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.18223475 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.17319924 |
| 95 | Leukocytosis (HP:0001974) | 2.17093746 |
| 96 | Skin nodule (HP:0200036) | 2.16371648 |
| 97 | Arterial thrombosis (HP:0004420) | 2.16292023 |
| 98 | Chronic diarrhea (HP:0002028) | 2.16089216 |
| 99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.14846076 |
| 100 | Pustule (HP:0200039) | 2.13214315 |
| 101 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12831739 |
| 102 | Abnormality of glycine metabolism (HP:0010895) | 2.12831739 |
| 103 | Recurrent viral infections (HP:0004429) | 2.11607302 |
| 104 | Lymphopenia (HP:0001888) | 2.11297591 |
| 105 | Decreased circulating renin level (HP:0003351) | 2.10066333 |
| 106 | Vertigo (HP:0002321) | 2.08442305 |
| 107 | Increased IgM level (HP:0003496) | 2.07394495 |
| 108 | Granulocytopenia (HP:0001913) | 2.07000979 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06465523 |
| 110 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06465523 |
| 111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06465523 |
| 112 | Hyperglycemia (HP:0003074) | 2.06205144 |
| 113 | Hyperglycinemia (HP:0002154) | 2.06033555 |
| 114 | Increased purine levels (HP:0004368) | 2.05238790 |
| 115 | Hyperuricemia (HP:0002149) | 2.05238790 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04919037 |
| 117 | Menorrhagia (HP:0000132) | 2.04126962 |
| 118 | Agammaglobulinemia (HP:0004432) | 2.03277689 |
| 119 | Generalized aminoaciduria (HP:0002909) | 2.02125147 |
| 120 | Late onset (HP:0003584) | 2.00453654 |
| 121 | Restrictive lung disease (HP:0002091) | 1.99663633 |
| 122 | Inflammation of the large intestine (HP:0002037) | 1.98685477 |
| 123 | Joint swelling (HP:0001386) | 1.98324083 |
| 124 | Thrombophlebitis (HP:0004418) | 1.97813167 |
| 125 | Glomerulopathy (HP:0100820) | 1.96729386 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.95727504 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.95319280 |
| 128 | Gangrene (HP:0100758) | 1.94672920 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.93448271 |
| 130 | IgM deficiency (HP:0002850) | 1.93372678 |
| 131 | Eosinophilia (HP:0001880) | 1.91213130 |
| 132 | Cellulitis (HP:0100658) | 1.90976685 |
| 133 | IgA deficiency (HP:0002720) | 1.90923765 |
| 134 | Fatigue (HP:0012378) | 1.90311603 |
| 135 | Metabolic acidosis (HP:0001942) | 1.90159516 |
| 136 | Right ventricular cardiomyopathy (HP:0011663) | 1.90064627 |
| 137 | Sepsis (HP:0100806) | 1.89328005 |
| 138 | Abnormality of the pleura (HP:0002103) | 1.89085732 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.88753532 |
| 140 | Dysostosis multiplex (HP:0000943) | 1.88475158 |
| 141 | Vasculitis (HP:0002633) | 1.87823261 |
| 142 | Increased mean platelet volume (HP:0011877) | 1.87350086 |
| 143 | Impaired platelet aggregation (HP:0003540) | 1.86685240 |
| 144 | Abnormal platelet function (HP:0011869) | 1.86685240 |
| 145 | Epistaxis (HP:0000421) | 1.84700693 |
| 146 | Recurrent sinusitis (HP:0011108) | 1.84683729 |
| 147 | Subacute progressive viral hepatitis (HP:0006572) | 1.84634342 |
| 148 | Amyloidosis (HP:0011034) | 1.84545248 |
| 149 | Gastrointestinal inflammation (HP:0004386) | 1.84149136 |
| 150 | Emphysema (HP:0002097) | 1.84106790 |
| 151 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83145588 |
| 152 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83145588 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83145588 |
| 154 | Acute hepatic failure (HP:0006554) | 1.82687612 |
| 155 | Abnormality of macrophages (HP:0004311) | 1.82525143 |
| 156 | Polycythemia (HP:0001901) | 1.82461411 |
| 157 | Arthralgia (HP:0002829) | 1.81796895 |
| 158 | Vascular calcification (HP:0004934) | 1.81450274 |
| 159 | Tetraparesis (HP:0002273) | 1.80486241 |
| 160 | Hypoglycemic seizures (HP:0002173) | 1.79933402 |
| 161 | Abnormality of the peritoneum (HP:0002585) | 1.79224057 |
| 162 | Mucopolysacchariduria (HP:0008155) | 1.79152456 |
| 163 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79152456 |
| 164 | Ventricular fibrillation (HP:0001663) | 1.78305458 |
| 165 | Increased cerebral lipofuscin (HP:0011813) | 1.77704898 |
| 166 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75543220 |
| 167 | Papilloma (HP:0012740) | 1.74644323 |
| 168 | Verrucae (HP:0200043) | 1.74644323 |
| 169 | Meningitis (HP:0001287) | 1.74321930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.44104871 |
| 2 | RIPK4 | 3.37470384 |
| 3 | MAP4K1 | 3.05386931 |
| 4 | MAP3K14 | 2.68956641 |
| 5 | TYK2 | 2.53586127 |
| 6 | ERN1 | 2.53256263 |
| 7 | IRAK3 | 2.47747196 |
| 8 | TAOK3 | 2.41667351 |
| 9 | JAK3 | 2.11056960 |
| 10 | FGFR4 | 2.07568494 |
| 11 | MAP3K13 | 2.05141336 |
| 12 | * JAK1 | 2.04049805 |
| 13 | TRIB3 | 1.92310214 |
| 14 | FRK | 1.91293981 |
| 15 | TBK1 | 1.82935511 |
| 16 | SIK1 | 1.80021495 |
| 17 | FGFR3 | 1.79853134 |
| 18 | INSRR | 1.78613136 |
| 19 | RIPK1 | 1.66083960 |
| 20 | IKBKE | 1.65782881 |
| 21 | CAMK1D | 1.60910901 |
| 22 | SGK3 | 1.52388110 |
| 23 | DAPK2 | 1.50816922 |
| 24 | BCKDK | 1.43431943 |
| 25 | MAP3K10 | 1.41662723 |
| 26 | SGK2 | 1.37755386 |
| 27 | GRK6 | 1.30101548 |
| 28 | PIK3CG | 1.29566537 |
| 29 | TGFBR2 | 1.28983578 |
| 30 | CSK | 1.26897526 |
| 31 | IRAK4 | 1.26846435 |
| 32 | FGR | 1.26560583 |
| 33 | * JAK2 | 1.26369437 |
| 34 | NEK9 | 1.21606905 |
| 35 | AKT3 | 1.19760077 |
| 36 | CAMK1G | 1.18139308 |
| 37 | TXK | 1.17955314 |
| 38 | SIK2 | 1.17918064 |
| 39 | PKN2 | 1.17667528 |
| 40 | PTK6 | 1.16395752 |
| 41 | MAP2K3 | 1.10123261 |
| 42 | TTN | 1.09961298 |
| 43 | IKBKB | 1.09565828 |
| 44 | ZAP70 | 1.06704896 |
| 45 | MST1R | 1.06095449 |
| 46 | MARK3 | 1.05894139 |
| 47 | MAP3K7 | 1.05456929 |
| 48 | CHUK | 1.04911096 |
| 49 | CSF1R | 1.04260298 |
| 50 | SYK | 1.03286834 |
| 51 | MAP3K3 | 1.02530252 |
| 52 | TAOK2 | 1.02408689 |
| 53 | STK10 | 1.01740327 |
| 54 | BTK | 0.98039673 |
| 55 | PRKAA2 | 0.96522583 |
| 56 | ITK | 0.94673880 |
| 57 | KIT | 0.93888386 |
| 58 | IRAK1 | 0.92209001 |
| 59 | BLK | 0.89780355 |
| 60 | PRKCH | 0.89528559 |
| 61 | MARK2 | 0.85601540 |
| 62 | CAMKK2 | 0.84019293 |
| 63 | LATS1 | 0.83235837 |
| 64 | TAOK1 | 0.83192629 |
| 65 | * PDK1 | 0.82531888 |
| 66 | MAP3K6 | 0.82372722 |
| 67 | HCK | 0.81706584 |
| 68 | CDK12 | 0.77521827 |
| 69 | STK24 | 0.77247369 |
| 70 | MATK | 0.76876702 |
| 71 | MAP3K1 | 0.76863839 |
| 72 | FES | 0.76633441 |
| 73 | TEC | 0.75142403 |
| 74 | MAPK11 | 0.74607717 |
| 75 | WNK1 | 0.71645141 |
| 76 | EPHB1 | 0.71462613 |
| 77 | * PDPK1 | 0.71060827 |
| 78 | SIK3 | 0.69349095 |
| 79 | PDK3 | 0.69206643 |
| 80 | PDK4 | 0.69206643 |
| 81 | IRAK2 | 0.67953975 |
| 82 | YES1 | 0.65731231 |
| 83 | CAMKK1 | 0.65425764 |
| 84 | PRKAA1 | 0.64729936 |
| 85 | LMTK2 | 0.63850175 |
| 86 | BMPR2 | 0.60953349 |
| 87 | PTK2B | 0.59972540 |
| 88 | GRK5 | 0.59435180 |
| 89 | MAP3K11 | 0.58941875 |
| 90 | ERBB4 | 0.58204098 |
| 91 | PRKCQ | 0.57786281 |
| 92 | LCK | 0.57424698 |
| 93 | EPHA3 | 0.57169290 |
| 94 | MAPK12 | 0.57167163 |
| 95 | CAMK4 | 0.56743630 |
| 96 | KSR2 | 0.56234419 |
| 97 | GRK7 | 0.55164179 |
| 98 | LRRK2 | 0.55062877 |
| 99 | PDK2 | 0.54701840 |
| 100 | FYN | 0.54644896 |
| 101 | SGK494 | 0.53546355 |
| 102 | SGK223 | 0.53546355 |
| 103 | LYN | 0.52929913 |
| 104 | MAP3K2 | 0.51500101 |
| 105 | MAP2K4 | 0.51491124 |
| 106 | STK38 | 0.48603558 |
| 107 | CDK6 | 0.47025519 |
| 108 | NLK | 0.45875369 |
| 109 | RAF1 | 0.45393025 |
| 110 | EGFR | 0.44976141 |
| 111 | CDC42BPA | 0.44167762 |
| 112 | DDR2 | 0.43816151 |
| 113 | MAPK7 | 0.43028694 |
| 114 | HIPK2 | 0.42866128 |
| 115 | ABL1 | 0.42770133 |
| 116 | PDGFRB | 0.42178915 |
| 117 | TRPM7 | 0.41453391 |
| 118 | MAP2K6 | 0.40166308 |
| 119 | RET | 0.39140557 |
| 120 | MAPK4 | 0.38860235 |
| 121 | TNK2 | 0.37562364 |
| 122 | * SGK1 | 0.36373951 |
| 123 | MYLK | 0.36358187 |
| 124 | NEK6 | 0.35809405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.63800154 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32661042 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.83030635 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63503096 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57445727 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55687255 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47628722 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.27663103 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20662683 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17032244 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16828389 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10772109 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02390753 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88594953 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85330349 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85264497 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68726840 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68419505 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61894596 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.54980789 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50111531 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.49204341 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.49002565 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.41614903 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40672041 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37711358 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35770314 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34647599 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33563327 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.31705428 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.27828898 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.26623111 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25405844 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23806301 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23586400 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20087776 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17922928 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.17363517 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16298623 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.15574919 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12431825 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11015151 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09227996 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08947021 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08407764 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08389733 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06299615 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04959392 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03380783 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02826442 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02640617 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00382867 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99353073 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.98968024 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98571077 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97375326 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95073791 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94352836 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94217956 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93061659 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92334140 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91303888 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87834406 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87822044 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86567842 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85279498 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85114848 |
| 68 | * Apoptosis_Homo sapiens_hsa04210 | 0.85030792 |
| 69 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84310123 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84190052 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84144612 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84105614 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82645601 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81577990 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79773770 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77219293 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76915334 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75907278 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.74718137 |
| 80 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74309478 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72371599 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72319286 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71677020 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70932125 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70171312 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69692002 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69458700 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68287563 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67433473 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.66681079 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66523305 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.66004537 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65672047 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.65640572 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65382126 |
| 96 | Measles_Homo sapiens_hsa05162 | 0.65377481 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.64403733 |
| 98 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.64283297 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64262141 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63557898 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62887992 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.62880864 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62709149 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62354804 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62105033 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61890943 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.61430071 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58910408 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58071258 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.56753468 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56327315 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54557195 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54225412 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54205954 |
| 115 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53422959 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52916926 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52753643 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52493268 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52010438 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51657434 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51643187 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51502468 |
| 123 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51195777 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50647076 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49852204 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49643419 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49067170 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49056496 |
| 129 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46446494 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46402619 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46399839 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46182836 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45686560 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.45684248 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45626016 |
| 136 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45353444 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.42261259 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41196820 |
| 139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39923902 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39761487 |
| 141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37556276 |
| 142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37412759 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35377965 |
| 144 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35166267 |
| 145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35051825 |
| 146 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34866372 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.33329459 |
| 148 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32824980 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32779892 |
| 150 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32407594 |
| 151 | Prion diseases_Homo sapiens_hsa05020 | 0.32168253 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.31886553 |

